Skip to content

Effect of ultrasound-guided stellate ganglion block on emergence quality and early recovery after robot-assisted radical prostatectomy

Effect of ultrasound-guided stellate ganglion block on emergence quality and early recovery after robot-assisted radical prostatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126009
Enrollment
Unknown
Registered
2026-06-02
Start date
2026-06-10
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence and Postoperative Recovery Quality in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy

Interventions

Stellate ganglion block group:Perform ultrasound-guided left stellate ganglion block (SGB), advance the needle tip to the anterior aspect of the longus colli muscle fascia, and after negative aspirati
Control group:For patients in group C, the same procedure as in group S was performed, with injection of 8 mL of normal saline.

Sponsors

The First Affiliated Hospital of Nanjing Medical University / Jiangsu Province Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Elective robot-assisted radical prostatectomy; 2. Aged >=55 and <=75 years, male; 3. ASA physical status class I or II; 4. Receiving ultrasound-guided stellate ganglion block

Exclusion criteria

Exclusion criteria: 1. Contraindications to stellate ganglion block (thoracic infection; infectious diseases of the skin or soft tissue at the puncture site, or presence of tumor; unclear or abnormal anatomical location of the puncture site, unclear surface landmarks; presence of coagulopathy; allergy to local anesthetics); 2. Long-term use of chronic analgesic drugs; 3. Severe sinus bradycardia, atrioventricular block, or sick sinus syndrome; 4. Previous chronic lung disease with pulse oxygen saturation <90% without oxygen inhalation; 5. Severe liver dysfunction (liver enzymes exceeding 3 times the upper limit of normal and serum albumin concentration below the normal reference range); 6. Severe renal insufficiency requiring preoperative renal replacement therapy; 7. Stroke, schizophrenia, depression, Parkinson's disease, epilepsy or dementia; Illiterates, language barriers or significant hearing or vision impairments that prevent communication

Design outcomes

Primary

MeasureTime frame
Riker Sedation-Agitation Scale (SAS) Score during Emergence;Safety Outcomes (including postoperative nausea and vomiting, neurological complications, adverse events);

Secondary

MeasureTime frame
Ramsay Sedation Scale Score;Visual Analog Scale (VAS) Score;Quality of Recovery-15 (QoR-15) Score at Postoperative Day 1 and Day 3;Time to Spontaneous Respiration Recovery;Time to Emergence;Time to Extubation;

Countries

China

Contacts

Public ContactChen Ziyang

The First Affiliated Hospital of Nanjing Medical University / Jiangsu Province Hospital

chenzy0627@126.com+86 135 1251 6397

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026